Community pharmacies face pandemic-related costs of '￡400m and rising’ , says negotiator

摘要

The Royal Pharmaceutical Society has made this article free to access in order to help healthcare professionals stay informed about an issue of national importance. To learn more about coronavirus, please visit:?https://www.rpharms.com/resources/pharmacy-guides/wuhan-novel-coronavirus (https://www.rpharms.com/resources/pharmacy-guides/wuhan-novel-coronavirus) Community pharmacies have incurred additional costs of more than ￡400m “and rising” because of the COVID-19 pandemic, pharmacy negotiators have said.